<DOC>
	<DOC>NCT01384214</DOC>
	<brief_summary>The purpose of this study is to evaluate swallowing efficiency in patients with cervical dystonia following treatment with botulinum toxin Type A.</brief_summary>
	<brief_title>Effect of Botulinum Toxin Type A on Swallowing in Patients With Cervical Dystonia</brief_title>
	<detailed_description />
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Diagnosed with cervical dystonia Successfully completed Allergan study MedAff BTX0616 with 16 weeks since last botulinum toxin Type A injection In need of additional botulinum toxin Type A injections Surgery or spinal cord stimulation for cervical dystonia Previous injections of phenol or alcohol for cervical dystonia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>